Intensive Outpatient Addiction Programs: The future of recovery?

Dr. Robert L. Tanguay and Colonel (Ret’d) Dr. Rakesh Jetly

April 12th 2022 1:30 pm Walker Banner Room

Session Description

Intensive Outpatient Programs for addiction and mental health are an important fixture in a Recovery Orientated System of Care. Concurrent programs are the gold standard but is also often not available. Trauma and PTSD are often co-morbid with addiction, especially in our first responders, yet little research and little access to trauma therapy is available. Chronic pain is often ignored yet has significant effect on prognosis. We will discuss treatment options for recovery from addiction, operational stress injuries and PTSD, and chronic pain, enhancing a ROSC.

Learning Objectives:

1. Learners will be able to apply appropriate treatment algorithms and evidence-based psychometrics for the diagnosis of PTSD and other mental health disorders.

2. Learners will gain knowledge in Intensive Outpatient Programs and apply the data comparing inpatient vs outpatient treatment using the ASAM Criteria.

3. Learners will gain knowledge on addiction medicine and mental health’s role in the treatment of addiction in a ROSC. 

References:

Ivan Ezquerra-Romano, Lawn, Krupitsky, Morgan, Ketamine for the treatment of addiction: Evidence and potential mechanisms, Neuropharmacology, Volume 142, 2018, Pages 72-82, ISSN 0028-3908, https://doi.org/10.1016/j.neuropharm.2018.01.017.

Dennis McCarty, Lisa Braude, D. Russell Lyman, Richard H. Dougherty, Allen S. Daniels, Sushmita Shoma Ghose, and Miriam E. Delphin-Rittmon Substance Abuse Intensive Outpatient Programs: Assessing the Evidence; Psychiatric Services 2014 65:6, 718-726

Barbara K Bujak, Elizabeth Regan, Paul F Beattie, and Shana Harrington, The effectiveness of interdisciplinary intensive outpatient programs in a population with diverse chronic pain conditions: a systematic review and meta-analysis; Pain Management 2019 9:4, 417-429

Bio

Colonel (Ret’d) Dr. Rakesh Jetly

Dr. Jetly is Chief Strategic Officer for The Newly Institute. He recently retired from the military as the chief of psychiatry for the Canadian armed forces after 31 years of service. During his time with the military, Dr. Jetly accumulated extensive deployment experience including Rwanda, the Middle East and two deployments to Kandahar Afghanistan. Along with his current role at The Newly, Dr. Jetly serves as an associate professor of psychiatry at Dalhousie University (Halifax) and the University of Ottawa. As an international expert he has published numerous articles in peer-reviewed professional journals and presents internationally on such topics as post-traumatic stress disorder and operational psychiatry. Col Jetly was promoted to his retired rank in 2011 and appointed senior psychiatrist and mental health clinical advisor to the CF Surgeon General. He was additionally appointed in 2015 “The Canadian Forces Brigadier Jonathan C. Meakins, CBE, RCAMC Chair in Military Mental Health”. Col Jetly was appointed to the Order of Military Merit as an Officer in 2009. 

Dr. Robert L. Tanguay

  • BSc (Hons), MD, FRCPC, CISAM, CCSAM 
  • Chief Medical Officer, The Newly Institute
  • Clinical Assistant Professor, University of Calgary 
  • Departments of Psychiatry and Surgery
  • President, Pain Society of Alberta
  • Alberta and NWT Regional Director, CSAM
  • Co-Lead, Alberta Pain Strategy, AHS
  • Founder and Clinic Lead, Opioid Deprescribing Program, AHS
  • Co-Founder and Co-Lead, Community RAAM, AHS
  • Hotchkiss Brain Institute & Mathison Centre for Mental Health

Dr. Tanguay is a Psychiatrist who completed two fellowships, one in Addiction Medicine and one in Pain Medicine. He is a clinical assistant professor with the departments of Psychiatry and Surgery at the Cumming School of Medicine, University of Calgary.

Most recently Dr. Tanguay helped found and is the Chief Medical Officer and Vice President of The Newly Institute, a program dedicated to providing medical and psychological intervention for people living with complex and treatment-resistant mental health disorders such as PTSD, depression, anxiety, addiction, and chronic pain including access to psychedelic-assisted psychotherapy. He is the former Medical Lead for the Alberta Addiction Education Sessions for Alberta Health Services (AHS). He is the Regional Director for Alberta and North West Territories for the Canadian Society of Addiction Medicine (CSAM) where he sits as a board member, the President of the Pain Society of Alberta, and the co-chair of the internationally recognized Alberta Pain Strategy.  He is the founder of the Opioid Deprescribing Program with AHS, the Rapid Access Addiction Medicine (RAAM) Community Clinic with AHS, and the Transitional Outpatient Pain Program for Spine (TOPPS) clinic working with spinal surgeons to optimize spinal surgery outcomes.

Academically, he is involved in research in trauma, addiction, chronic pain, opioids, cannabis, and psychedelics and is a member of the Hotchkiss Brain Institute and the Mathison Centre for Mental Health Research & Education at the University of Calgary.